Cancer Research and Novel Drug Development

Theme : Advancing precision medicine for targeted and personalized cancer therapies.

+916304117143

Supported by

Logo
Logo
Logo
Logo
Logo
Logo

About Cancer Summit-2025

Dear Esteemed Participants,
The Global Conference on Cancer Research and Novel Drug Development (Cancer Summit-2025), scheduled for November 17-19, 2025, in Tokyo, Japan, will serve as a premier platform for oncologists, researchers, pharmaceutical experts, and healthcare professionals to explore the latest advancements in cancer treatment and drug discovery. The conference will cover a wide range of topics, including cancer biology, precision medicine, immunotherapy, targeted drug development, and emerging technologies such as AI-driven oncology and nanomedicine. Discussions will also focus on advancements in clinical trials, biomarker discovery, and innovative screening techniques to improve early detection and patient outcomes. Through keynote presentations, panel discussions, workshops, and networking sessions, the summit aims to foster interdisciplinary collaboration and accelerate breakthroughs in cancer therapeutics. By bringing together experts from academia, industry, and healthcare, Cancer Summit-2025 will play a crucial role in shaping the future of oncology and revolutionizing cancer treatment strategies worldwide.

Submit Abstract Registration

Tokyo, Japan Tour

▶

Important Dates

First round of abstract submission is closing on July 10, 2025 | Early bird registration is closing on July 11, 2025

Chair Welcome Message

Dear Colleagues and Esteemed Guests,
Welcome to the Global Conference on Cancer Research and Novel Drug Development – Cancer Summit 2025, taking place from November 17–19, 2025, in Tokyo, Japan.
As Chair of this important summit, it is my great honors to extend a warm welcome to all participants. This global gathering serves as a vital platform to explore breakthroughs in cancer biology, diagnostics, therapeutics, and the development of next-generation drugs.
Over the course of these three days, we will engage in transformative discussions, share groundbreaking research, and strengthen international collaborations in the fight against cancer. Your insights and contributions will be essential as we aim to advance science, improve patient outcomes, and shape the future of oncology.
I encourage each of you to actively participate—whether by presenting, networking, or learning from fellow experts. Together, we can accelerate innovation and drive progress toward a cancer-free world.
Thank you for joining us, and I look forward to a highly productive and inspiring Cancer Summit 2025.

Warm regards,
Dr. Chintan P. Shah,
Department of  General Oncology
University of Texas, USA


Best wishes,

Dr. Chintan P. Shah

Department of General Oncology, University of Texas, USA

Publishing Partners

We are proud to collaborate with esteemed publishing partners for the Global Conference on Cancer Research and Novel Drug Development (Cancer Summit-2025), taking place from November 17-19, 2025, in Tokyo, Japan. This conference offers participants the opportunity to publish their full papers in renowned journals and official conference proceedings, ensuring global visibility and academic recognition. All accepted abstracts and papers will be included in the conference proceedings with an ISBN number, while selected high-quality papers will be considered for publication in prestigious, peer-reviewed international journals indexed in Scopus, Web of Science, and PubMed. Additionally, each published paper will receive a Digital Object Identifier (DOI) for easy citation and reference. To further enhance accessibility and impact, authors will also have the option to publish their work as open access. By joining Cancer Summit-2025, researchers and professionals can contribute to groundbreaking advancements in cancer research while gaining international exposure for their work.

Our Speakers

Charles Lockwood

University of South Florida, USA

Sarah Underwood,

Olivia Newton-John Cancer Wellness University, Australia

A. Thomas Look

Harvard University, USA

Bo Lu

Thomas Jefferson University, USA

Avi B. Markowitz

The University of Texas MD Anderson, USA

Drew Weissman

University of Pennsylvania, USA

Francisco J. Esteva

Lenox Hill University, USA

Tian-Li Wang

Johns Hopkins Medical University, USA

View All

Registration Slots

Delegate/Listener (In-Person)

$849 USD

  • Entrance
  • Lunch & Coffee Break on all days
  • Certificate
  • E-Abstract Book
Register Now
Speaker (In-Person)

$749 USD

  • Entrance
  • Lunch & Coffee Break on all days
  • Full Paper Publication
  • Certificate & E-Abstract Book
Register Now
Poster/Student

$549 USD

  • Entrance
  • Lunch & Coffee Break on all days
  • Certificate
  • E-Abstract Book
Register Now
Virtual (Speaker/Delegate)

$399 USD

  • Entrance
  • Lunch & Coffee Break on all days
  • Certificate
  • E-Abstract Book
Register Now

Topics

Tumor Microenvironment and Cancer Progression
Genetic and Epigenetic Alterations in Cancer
Cancer Stem Cells and Metastasis
Role of Inflammation and Immunity in Cancer Development
Advances in Immunotherapy and Checkpoint Inhibitors
CAR-T Cell Therapy and Personalized Immunotherapy
Neoantigen-Based Cancer Vaccines
Precision Medicine and Genomics in Oncology
Predictive and Prognostic Biomarkers in Cancer
Artificial Intelligence in Cancer Diagnostics and Treatment
Targeted Therapies and Small-Molecule Inhibitors
RNA-Based Therapies and Gene Editing in Cancer Treatment
Overcoming Drug Resistance in Cancer Therapy
AI-Driven Drug Discovery and Repurposing Strategies
Tumor Heterogeneity and Its Impact on Treatment
Liquid Biopsy and Non-Invasive Diagnostic Tools
Advances in Cancer Imaging and Early Detection Technologies
Nanotechnology for Cancer Treatment and Drug Delivery
Organoid and 3D Tissue Models for Cancer Research
Metabolic Reprogramming in Cancer Cells
Role of Microbiome in Cancer Development and Therapy
Novel Strategies in Radiation and Combination Therapies
Innovations in Cancer Surgery and Minimally Invasive Techniques
Ethical Considerations in Oncology Research and Clinical Trials
Cancer Prevention Strategies and Risk Reduction
Palliative Care and Supportive Treatments for Cancer Patients
Quality of Life and Rehabilitation in Cancer Survivorship
Public Health Policies and Global Cancer Control Strategies
Advances in Pediatric Oncology and Rare Cancers
Real-World Data and Evidence-Based Oncology Practices

Conference Schedule

Venue

Tokyo Prince Hotel, Tokyo, Japan

Contact Us

Contact us for more details

Media Partner

Logo
Logo
Logo
Logo
Logo